A structured checklist for buyers evaluating IVF practices — from physician retention risk and SART outcomes to laboratory accreditation and payer mix analysis.
Find Fertility Clinic Acquisition TargetsAcquiring a fertility clinic requires scrutiny well beyond standard healthcare M&A. Success rates are publicly reported, physician dependency is acute, and regulatory obligations span CLIA, SART, CDC, and state corporate practice of medicine laws. This guide walks buyers through three critical phases to protect deal value and avoid post-close surprises.
Validate the clinic's licensure, accreditation standing, and published clinical outcomes before advancing toward LOI or exclusivity.
Review last three years of SART-reported IVF success rates and CDC ART data. Confirm rates meet or exceed national averages and identify any adverse reporting history.
Verify the IVF laboratory holds current CLIA certification and all state-required licenses. Confirm accreditations are transferable to the acquiring entity post-close.
Request five years of malpractice claims, patient complaints, and state health department citations. Unresolved claims or regulatory sanctions are serious red flags.
Evaluate dependency on the founding reproductive endocrinologist and assess the strength of employment agreements and staff retention plans.
Review all RE employment contracts, compensation terms, non-compete radius and duration, and tail malpractice coverage obligations triggered at separation.
Assess patient volume attributable to the founding physician. Quantify revenue at risk if departure occurs and evaluate associate RE bench strength and recruiting pipeline.
Identify credentialed embryologists, clinical coordinators, and nurses critical to lab operations. Review compensation, tenure, and any flight risk indicators post-announcement.
Analyze revenue quality, payer mix, capital requirements, and deal structure implications for post-close performance.
Break down revenue by self-pay IVF cycles, insurance mandates, and employer benefit contracts such as Progyny or WINFertility. Assess reimbursement rates and contract renewal terms.
Inspect age and condition of incubators, cryostorage systems, and genetic testing equipment. Obtain third-party estimates for near-term capital replacement requirements.
Engage a QoE provider to normalize founding physician compensation, personal expenses, and one-time items. Confirm true EBITDA supports the acquisition multiple being paid.
No. Fertility clinic acquisitions are not SBA eligible due to their healthcare nature and typical deal structures involving MSOs, physician equity rollovers, and earnout provisions that conflict with SBA requirements.
Expect five to nine times EBITDA depending on SART performance, physician stability, lab accreditation, and payer mix quality. Clinics with multiple REs and above-average success rates command the higher end.
Most deals use a Management Services Organization structure where the MSO owns non-clinical assets and the physician entity retains clinical operations, linked through a Professional Services Agreement compliant with state CPOM doctrine.
Patient volume and referral relationships can collapse rapidly. Mitigate this through a multi-year employment agreement with non-compete provisions, earnout tied to retention, and recruitment of an associate RE before closing.
More Fertility Clinic Guides
DealFlow OS surfaces targets with seller signals and motivation scores — so you know before you start diligence. Free to join.
Start finding deals — freeNo credit card required
For Buyers
For Sellers